Hung T. Khong, MD Associate Professor, Division of Oncology, University of Utah School of Medicine Investigator, Huntsman Cancer Institute Editor-in-Chief, Current Biomarker Findings Associate Editor, BMC Cancer Hung T. Khong, MD, is an associate professor in the Division of Oncology at the University of Utah School of Medicine and a Huntsman Cancer Institute investigator. Khong's research interests include cancer immunotherapy and epigenetic modulation in the treatment of cancer. His research focuses on adoptive cellular therapy and cancer vaccines (manipulation of the immune system to treat cancer), combining treatment methods: chemo- or radiotherapy with immunotherapy (using the immune system to enhance the effects of chemotherapy and/or radiotherapy) and chemotherapy with targeted therapy (drugs that intervene with specific molecules involved in tumor growth). Khong's clinical specialties are melanoma and breast cancer. Before joining the Huntsman Cancer Institute in December 2011, Khong was an associate professor and a former Associate Director for Clinical Research at the University of South Alabama Mitchell Cancer Institute in Mobile, Alabama. At the National Cancer Institute in Bethesda, Maryland, Khong was a senior clinical fellow in the surgery branch and also completed a medical oncology fellowship in the medicine branch. He completed a residency in the Internal Medicine Program at Baylor College of Medicine in Houston, Texas. Khong earned a medical degree from Temple University School of Medicine in Philadelphia, Pennsylvania.